CD40LG and brucellosis: Notably, we observed S19-vaccinated sIgM−/−/AID−/− mice, which lack the capacity to produce both IgM and class-switched antibodies, demonstrated enhanced susceptibility to brucellosis 2 weeks after challenge (Fig. 4A and C).